Singapore start-up uses peptides to fight pet infections
Healbac, a Singaporean biotech spin-off, is utilizing stem-cell-derived antimicrobial peptides to treat pet infections. The startup is currently collaborating with local veterinary clinics to build clinical data for their topical treatments.
Why it matters
By providing an alternative to traditional antibiotics, this technology addresses the risk of superbug development in veterinary medicine.
Itchy and scratchy: Bazel the beagle could soon find relief from his itchy skin with a new peptide-based cream.
Listen Summarise Healbac, a Singapore biotech spin-off, uses stem-cell derived antimicrobial peptides to fight germs and reduce reliance on antibiotics and harmful food preservatives. The startup is first testing topical pet treatments for skin and ear infections, aiming to give vets an option before systemic antibiotics are used. Its cream cured a French bulldog in three days, and Healbac now works with six Singapore vet clinics while building clinical data and planning future sales. AI generated
SINGAPORE – Every pet owner dreads it when a dog’s itchy skin or a cat’s ear irritation snowballs into costly vet visits and a 14-day regimen of strong antibiotics.
Also covering this story
One other newsroom covered this event. We read that version too.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in